IHS Chemical Week

People & Business :: Companies

Evonik: Ebitda falls 24% on organic sales growth of 1%; reiterates outlook for 2014

7:45 AM MDT | May 7, 2014 | Michael Ravenscroft

Evonik says it achieved sales of €320 billion ($4.45 billion) in first-quarter 2014, close to the prior-period level of €3.21 billion, a slight organic sales growth of 1% year-on- year. Higher volumes (5 percentage points) countered the drop in selling prices (4 percentage points), and adverse currency effects clipped sales by 1 percentage point, according to Evonik. Adjusted Ebitda slipped to €463 million, compared with €606 million in the year-ago quarter, or 24% YOY, falling short of the very good level in the prior-period, according to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa